A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple ascending doses of LAD603 in healthy adult participants in both Part 1 and 2.
Epistemonikos ID: 7b69634668fbed76b710b9f9e78b0e583db075fc
First added on: May 15, 2024